Curative Biotechnology Stock

Curative Biotechnology P/B

The P/B (Price-to-Book Ratio) of Curative Biotechnology (CUBT) as of Aug 10, 2026 is 4.35. In the previous year, P/B (Price-to-Book Ratio) was 4.54 — a change of -4.32% (lower).

P/B

4.35

YoY

-4.32%

Last updated:

P/B (Price-to-Book Ratio) of Curative Biotechnology is 2026 4.35 . P/B (Price-to-Book Ratio) of Curative Biotechnology was 2025 4.54 . It decreases by -4.32% lower compared to the previous year.
Access this data via the Eulerpool API

Curative Biotechnology Stock analysis

What does Curative Biotechnology do? Curative Biotechnology is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Curative Biotechnology stock

P/B (Price-to-Book Ratio) of Curative Biotechnology is 4.35 in 2026.

P/B (Price-to-Book Ratio) of Curative Biotechnology changed from 4.54 to 4.35, representing a -4.32% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of P/B (Price-to-Book Ratio) Curative Biotechnology since 2006 – with annual values, charts, and detailed analysis.

The Price-to-Book ratio compares a company's market price to its book value. A low P/B may indicate an undervalued stock, while a high P/B could suggest overvaluation or strong growth expectations.

P/B = Stock Price / Book Value per Share

To evaluate P/B (Price-to-Book Ratio)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for P/B (Price-to-Book Ratio).

A 'good' varies by industry and company stage. On Eulerpool, you can compare P/B (Price-to-Book Ratio)'s Curative Biotechnology with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

Valuation — Curative Biotechnology

All Key Metrics — Curative Biotechnology